创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

CHEN Peiran, ZHAO Liwen, HUANG Fengjie. Advance in Research on the Function of Immune Checkpoint B7-H3 in Cancer[J]. Progress in Pharmaceutical Sciences, 2023, 47(6): 471-480. DOI: 10.20053/j.issn1001-5094.2023.06.009
Citation: CHEN Peiran, ZHAO Liwen, HUANG Fengjie. Advance in Research on the Function of Immune Checkpoint B7-H3 in Cancer[J]. Progress in Pharmaceutical Sciences, 2023, 47(6): 471-480. DOI: 10.20053/j.issn1001-5094.2023.06.009

Advance in Research on the Function of Immune Checkpoint B7-H3 in Cancer

  • Immune checkpoints are molecules present on the surface of immune cells, and are critical in regulating immune responses. In recent years, a large number of immune checkpoints have been identified as abnormally expressed on cancer cells, and have been found to be closely associated with tumor progression. Based on those immune checkpoints, many anticancer therapies, e.g. mAbs, chimeric antigen receptor T cells (CAR-T), and antibody conjugated drug (ADC), have been developed. B7-H3, a newly discovered immune checkpoint ubiquitously expressed by cancer tissues, is capable of driving tumor proliferation, immune evasion, drug resistance and metastasis. In an effort to provide some reference for drug development, this review summarizes recent studies of B7-H3 with its effects and mechanisms.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return